- Home
- TWST
as 05-20-2024 9:36am EST
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 2.7B | IPO Year: | 2018 |
| Target Price: | $42.50 | AVG Volume (30 days): | 945.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.62 - $50.50 | Next Earning Date: | 05-02-2024 |
| Revenue: | $277,486,000 | Revenue Growth: | 21.79% |
| Revenue Growth (this year): | 22.03% | Revenue Growth (next year): | 20.76% |
Share on Social Networks:
Stock Insider Trading Activity of Twist Bioscience Corporation (TWST)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| WERNER ROBERT F. | TWST | Chief Accounting Officer | May 3 '24 | Sell | $37.13 | 132 | $4,901.69 | 43,548 | SEC Form 4 |
| Cho Dennis | TWST | See Remarks | May 3 '24 | Sell | $37.13 | 568 | $21,092.11 | 80,436 | SEC Form 4 |
| Banyai William | TWST | See Remark | Apr 2 '24 | Sell | $32.74 | 327 | $10,704.67 | 345,986 | SEC Form 4 |
| Cho Dennis | TWST | See Remarks | Apr 2 '24 | Sell | $32.74 | 129 | $4,222.94 | 81,004 | SEC Form 4 |
| Leproust Emily M. | TWST | Chief Executive Officer | Mar 20 '24 | Sell | $33.52 | 1,128 | $37,806.05 | 515,281 | SEC Form 4 |
| Cho Dennis | TWST | See Remarks | Mar 20 '24 | Sell | $33.52 | 230 | $7,708.68 | 81,133 | SEC Form 4 |
| Banyai William | TWST | See Remark | Mar 20 '24 | Sell | $33.52 | 442 | $14,814.07 | 346,313 | SEC Form 4 |
| Green Paula | TWST | SVP of Human Resources | Mar 20 '24 | Sell | $33.52 | 200 | $6,703.20 | 92,650 | SEC Form 4 |
| Cho Dennis | TWST | See Remarks | Mar 14 '24 | Sell | $34.60 | 93 | $3,217.80 | 81,363 | SEC Form 4 |
| Cho Dennis | TWST | See Remarks | Mar 6 '24 | Sell | $37.43 | 272 | $10,180.96 | 81,456 | SEC Form 4 |
| WERNER ROBERT F. | TWST | Chief Accounting Officer | Mar 6 '24 | Sell | $37.43 | 181 | $6,774.83 | 43,680 | SEC Form 4 |
| Green Paula | TWST | SVP of Human Resources | Mar 6 '24 | Sell | $37.43 | 600 | $22,458.00 | 92,850 | SEC Form 4 |
Latest Twist Bioscience Corporation News
TWST Breaking Stock News: Dive into TWST Ticker-Specific Updates for Smart Investing
Business Wire
7 days ago
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
Business Wire
12 days ago
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Simply Wall St.
16 days ago
Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
MT Newswires
17 days ago
Sector Update: Health Care Stocks Mixed Late Afternoon
MT Newswires
17 days ago
Sector Update: Health Care Stocks Mixed in Afternoon Trading
MT Newswires
17 days ago
Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised
Insider Monkey
17 days ago
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript
Thomson Reuters StreetEvents
17 days ago